I just heard from a consulting company I’ve worked with in the past. They are offering $100 for anyone that has–or has had–head or neck cancer to take a short survey over the phone.
Individualized medicine is the hot catchphrase these days. But what about individualized dosing? Prompted by fellow myeloma patient and researcher, Gary Blau, I have been advocating more attention be paid to maximizing the timing and effectiveness of existing drugs.